A CEO said to me recently:
“We just need Congress to pass SBIR so we can move forward.”
I asked him a question he didn’t enjoy:
“What would you expect Congress to do, guarantee your revenue model?”
He paused.
Because buried inside the frustration was an assumption: that Small Business Innovation Research (SBIR) stability equals business stability.
Right now, many companies believe the program is delayed.
It isn’t.
It’s being renegotiated.
The Senate isn’t debating whether SBIR works.
They’re debating who SBIR is for.
Why It Missed NDAA and Appropriations
I expected SBIR to move with defense appropriations after it slipped past the National Defense Authorization Act (NDAA). Logical prediction. Didn’t happen.
Now it could attach to Department of Homeland Security (DHS) appropriations, reconciliation, or another moving vehicle.
That tells you something important.
This isn’t a timing problem.
This is a definition problem.
Senator Markey and Senator Ernst aren’t arguing over funding levels. They’re arguing over identity.
One side sees SBIR becoming a perpetual subsidy.
The other sees reforms shutting out real startups.
Neither side wants to permanently codify the other’s version.
So Congress waits until a bill forces compromise.
How surprised should we be that Congress won’t protect a business model it never intended to create?
The Uncomfortable Part
SBIR was designed as an on-ramp to procurement.
But over time, three behaviors emerged:
- Companies using SBIR to reach a Program of Record
- Companies surviving on SBIR cycles
- Companies built around SBIR harvesting
Congress is trying to preserve #1 while limiting #2 and #3.
That’s the fight.
Reliance on SBIR was never the goal.
It was evidence you deserved real funding.
The Question Most Companies Avoid
If you didn’t qualify for SBIR next year,…
How would your company reach the customer?
Not hypothetically. Operationally.
- Who owns the requirement?
- What budget pays for it?
- Why do they need it this fiscal year?
Because those answers, not the Phase II, have always determined survival. The fastest path out of the Valley of Death has never been another Phase II.
What Didn’t Stop
Even during the reauthorization pause:
- Programs still have funded problems
- Broad Agency Announcements (BAAs) still execute
- Other Transaction Authorities (OTAs) still execute
- Research, Development, Test, and Evaluation (RDT&E) lines still exist
- Congressional adds still happen
- Reprogramming still happens
The mission didn’t stop.
Only one contracting pathway paused.
Are you waiting for SBIR, or waiting for permission to sell?
SBIR is a contracting authority, not the innovation economy.
What Happens Next
SBIR reauthorization will pass.
But something will narrow:
- Repeat awards
- Eligibility
- Venture involvement
- Commercialization requirements
- Topic control
Waiting for certainty assumes the program returns unchanged.
It won’t.
What happens to your strategy the day your proposal is no longer eligible?
For Those Stuck Mid-SBIR
Some of you aren’t philosophically debating the program.
You’re simply parked.
Proposal submitted.
Follow-on paused.
Transition conversation frozen while everyone waits to see what Congress does.
Meanwhile, every other contracting lane looks like an expressway.
Here’s the uncomfortable question:
At what point does patience become a strategy instead of a delay?
You don’t control when Congress resolves this.
But you do control whether your company only moves when it does.
Smart people change their minds when the facts change.
Right now, the fact is simple:
SBIR is temporarily a speed bump in a road system that still has open lanes.
So operate accordingly.
Proceed as if Congress won’t act in time for your business plan.
- Map the requirement.
- Find the budget owner.
- Use the contracting pathways that are still moving.
Then, when SBIR resumes, you’re not saved by it.
You’re accelerated by it.
Are you building a company that depends on a legislative outcome, or one that benefits from it?
It’s an election year. This will get resolved.
But not on a timeline any single company can plan around, and not in a way everyone will like equally.
Waiting for clarity is comforting.
Operating without needing it is how federal companies grow.
Stop betting on Congress acting soon. Start positioning so it doesn’t matter when they do.
